SREBF1 and brain neoplasm: In addition to enrichment of HIF1A signaling, several other signaling pathways (SREBP1, E2F, AP2, NFY, and CDPCR3) also demonstrate enrichment in brain tumor samples across both our mouse and patient analyses (Supplementary Data 3 and 5).